论文部分内容阅读
环磷酰胺治疗流行性出血热,是目前正在探讨的治疗方法,作者通过治疗39例(环磷酰胺组18例,对照组21例)的观察,退热期:环组平均3.53天,对照组平均5.12天;尿蛋白转阴期:前者平均4.76天,后者平均7.13天,两组虽无显著性差异,但初步认为在疗效方面对体温改善、肾功能恢复等似有优越之处,且肾功能恢复较为突出,因而环磷酰胺治疗出血热,仍不失为一种良好辅助剂,值得进一步探讨。
Cyclophosphamide in the treatment of epidemic hemorrhagic fever is currently being explored in the treatment of 39 cases (cyclophosphamide group 18 cases, 21 cases of control group), the antipyretic phase: the ring group an average of 3.53 days, the control group An average of 5.12 days; urine protein negative: the former an average of 4.76 days, the latter an average of 7.13 days, although no significant difference between the two groups, but initially that the efficacy of the body temperature to improve, recovery of renal function seems to have advantages, and Renal function recovery is more prominent, so cyclophosphamide in the treatment of hemorrhagic fever, is still a good adjuvant, it is worth further study.